IHC results indicated that the lymphoma cells strongly and diffusely expressed CD10 and BCL-2, with scattered positivity for BCL-6 and CD5, 30% positivity for C-MYC, and negativity for MUM-1. This evidence concerns the gene BCL2 and lymphoma.